Showing results (181-190 of 291) with videos related to

Sort By:
Pageof 30
Anticancer Research|October 15, 2010
Optimized protocols for generation of cord blood-derived cytokine-induced killer/natural killer cellsYang Li, Ingo G H Schmidt-Wolf, Yan-Feng Wu, et al.
Acta Haematologica|May 5, 2025
Dose reduced induction therapy (A)-AIDA in patients with AML, being unfit for standard 7+3 chemotherapy and Literature Review of AML treatment in unfit/older AML patientsKarin Mayer, Leonie Birk, Katjana Schwab, et al.
German Medical Science : GMS E-Journal|August 14, 2009
High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphomaUlrich J M Mey, Vandana Jha, John W Strehl, et al.
Scientific Reports|April 12, 2025
Comprehensive bioinformatics and immunohistochemical analyses identify phosphoinositide metabolism and PNPLA7 as potential biomarkers in urological cancersYinhao Chen, Mingde Gao, Peng Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2006
Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cellsMaria A González-Carmona, Angela Märten, Per Hoffmann, et al.
Nuklearmedizin. Nuclear Medicine|June 30, 2025
Psycho-Oncological Screening Identifies High-Risk Subgroups Among Neuroendocrine Tumor Patients Undergoing PRRT with [177Lu]Lu-DOTATATE: Implications for SurvivalBarbara Kreppel, Hannah M Jochims, Milka Marinova, et al.
Cancer Research|December 26, 2003
Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor modelTanja Schmidt, Carsten Ziske, Angela Märten, et al.
Scientific Reports|July 2, 2025
Potential role of TNFRSF12A in linking glioblastoma and alzheimer's disease via shared tumour suppressor pathwaysTing Liu, Jingjing Pu, Sandra Theil, et al.
Cancer|February 28, 2006
Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter TrialRudolf Weiss, Paris Mitrou, Keikawus Arasteh, et al.
Patient Education and Counseling|December 26, 2021
Questions and emotional expressions from patients and companions while participating in multidisciplinary tumor conferences in breast and gynecological cancer centersBarbara Schellenberger, Christian Heuser, Annika Diekmann, et al.
Pageof 30